Status:
RECRUITING
Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Adrenal Incidentaloma
Hypercortisolism
Eligibility:
All Genders
18-80 years
Brief Summary
The investigators hypothesize that cardiovascular and metabolic alterations can occur in patients with adrenal adenomas and possible Autonomous Cortisol Secretion (pACS). Investigators hypothesize tha...
Detailed Description
Adrenal incidentalomas are clinically silent masses discovered inadvertently during diagnostic imaging procedures performed for unrelated reasons. Depending on the criteria applied, up to 50% of patie...
Eligibility Criteria
Inclusion
- Incidentally detected adrenal mass
Exclusion
- Patients with overt Cushing's syndrome, pheochromocytoma, Conn syndrome, adrenocortical carcinoma, late-onset congenital adrenal hyperplasia, adrenal metastasis and adrenal hemorrhage
- Patients taking medications influencing glucocorticoid production or metabolism
- Patients with psychiatric diseases or alcohol abuse
- Pregnancy
Key Trial Info
Start Date :
January 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04127552
Start Date
January 2 2019
End Date
December 31 2025
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Experimental Medicine
Rome, Italy, Italy, 00161